Le Lézard
Classified in: Science and technology, Business

SalesAgility announces the anticipated roadmap for SuiteCRM Outlook Integration


STIRLING, Scotland, Oct. 23, 2019 /PRNewswire-PRWeb/ -- SalesAgility are pleased to announce that active development is now underway for the next major version of SuiteCRM Outlook Add-in 4.0.0 ? the official SuiteCRM Outlook integration.

The new SuiteCRM Outlook Add-in will be released in three consecutive phases in order to promote and implement customer feedback in an agile way to each subsequent phase. With the announcement of SuiteCRM Outlook Add-in v4, SalesAgility are also therefore announcing the retirement of SuiteCRM Outlook Add-in v3.

"We want to thank all our customers who have worked with us and helped to develop and support the previous versions of the SuiteCRM Outlook Add-in. However, we feel that it has reached a point that in order for us to continue releasing a stable and robust solution, it is necessary to develop upon a newer codebase, using better technology and following latest best practises," said Ashley Nicolson, Head of Product & Community.

SuiteCRM Outlook Add-in v4 will be built upon the well documented and supported Microsoft Office Add-ins platform. Utilising this extensive platform will bring cross-platform support and centralised configuration to organisations giving them more control and the opportunity to adopt the latest web technology. This is the next generation of feature-rich and easy-to-use Office add-ins for SuiteCRM that are fast, robust and continuously evolving. Each of the three phases are explained below:

1st Phase:

The 1st phase will be the initial launch of the SuiteCRM Outlook Add-in v4. This release will introduce the user to the new SuiteCRM Outlook Add-in providing them with the ability to configure, connect and synchronise all their customer email history and correspondence to their SuiteCRM instance so they will never lose an important conversation again.

2nd Phase:

The roll out of the second phase will bring bi-directional calendar synchronisation. This will allow users to always keep their activities such as meetings, calls and tasks scheduled and updated within SuiteCRM, from their own private Outlook calendars, allowing all updates to be made from one place.

3rd Phase:

In the final Phase, SalesAgility will complement the launch of SuiteCRM Outlook Add-in v4 with both manual and automatic synchronisation of all the users' important Contacts, between their Outlook Contact lists and SuiteCRM. This will benefit the user as it will enable them to further develop their business relationships within SuiteCRM.

SalesAgility aim to have the roll out of each of the three phases, completed by the end of Q4 2019, with additional features and improvements to follow.

For more information, please contact:

Laura Kerr
Digital Marketing Executive
01786 585 499, [email protected] or check the SuiteCRM website: http://www.suitecrm.com

 

SOURCE SalesAgility


These press releases may also interest you

at 16:00
BerryDunn, a full-service assurance, tax, and consulting firm, is pleased to announce the hiring of Kevin Chartrand, MBA, PMP, CPHIMS, who brings over 15 years of state health and human services technology expertise to BerryDunn's growing Medicaid...

at 15:20
Aventiv Technologies, a communications and technology business serving the incarcerated, their friends and family, and state and local correctional facilities, today announced an agreement...

at 15:15
Dentsu announced today the official launch of Merkury for Media, the network's latest offering within its unrivaled global data, identity, and insights platform, Merkury. The new...

at 15:11
The technology service provider market is at a crucial turning point, marked by exponential technological innovation,...

at 15:10
ServiceChannel, the leading platform for the procurement and delivery of facilities services, announced today the introduction of new solutions that empower business operators to maximize their facilities investments. The Spring 2024 Product...

at 15:05
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent directors Cristian Luput and Ramiro Guerrero, J.D, LL.M. made individual...



News published on and distributed by: